CHAI Raises $400 Million in Funding
chaitjo · x · 2026-07-15
CHAI announced the completion of a $400 million funding round led by Dimension, with participation from Index, Kleiner Perkins, and Sequoia.
The post reflected on the company's journey from sharing early office space to its current focus on generative molecular design, having secured partnerships with Lilly, Pfizer, and Novartis. It also mentioned their release of the open-source Chai-1, positioned as a frontier model for biomolecular interactions. The author emphasized that this funding round will reshape preclinical and even clinical-stage drug discovery and R&D.
Related event: AI Drug Discovery Firm Chai Raises $400M(3 posts)→
More from Venture
- Steal this idea: prompt-to-hardware where agents assemble custom devices — paraschopra · 2026-09-11
- Marc Loou gives away free book on making $3M from 36 startups, 90% of them failures — marclou · 2026-09-11
- Trucking brokerage acquired for its AI platform and 8,000-carrier network, not revenue — MatthewChang · 2026-09-11
- Investor argues Palantir-Nvidia partnership should slash Anthropic's IPO valuation — pdamodaran · 2026-09-11
- Moonshot's annualized revenue jumped from $300M to $1B in two months after Kimi K3 — Hesamation · 2026-09-11
- Mid-market companies' AI SEO bottleneck is ops execution, not strategy, says SEO practitioner — gaganghotra_ · 2026-09-11